top of page

Ankit Bharat, MD: Lung Transplants (WARNING: Graphic Medical Content)

Ankit Bharat, MD

Professor & Chief, Thoracic Surgery

Executive Director, Canning Thoracic Institute

Northwestern University


This video was recorded during the LiveLung Virtual Lung Cancer Group on December 13, 2023.


WARNING: This video contains graphic medical content that might be disturbing to some viewers. Viewer discretion is advised.




About the Speaker: Dr. Ankit Bharat is a board-certified thoracic surgeon and general surgeon whose clinical focus is on the treatment of malignant and benign chest diseases, including lung cancer and malignant pleural mesothelioma. He is the Chief of Thoracic Surgery at Lurie Cancer Center and Northwestern Medicine, as well as the Harold L. and Margaret N. Method Professor of Surgery and Medicine at Feinberg School of Medicine and the inaugural director of Lung Transplant and Lung Rescue Programs at Northwestern University- Northwestern Medicine in Chicago.[1] In addition to performing one of the first thoracic chemoperfusion procedures in Illinois, he also performed the United States’ first double lung transplant on a patient with COVID-19.


Dr. Bharat began his medical education at the Christian Medical College in Vellore, India. He completed his general and cardiothoracic surgery training at Washington University in St Louis, where he was one of the first international medical graduates to be accepted for residency training. Following being mentored there by surgical and scientific pioneers, he pursued cardiothoracic surgery training at institutions including Memorial Sloan Kettering Cancer Center in New York, MD Anderson in Houston, Toronto General Hospital in Canada, and Barcelona University Hospitals in Spain. Following his years as a fellow at Washington University in St. Louis, he moved on to Northwestern Medicine.


Dr. Bharat’s research is focused on lung cancer and other malignancies, as well as on lung preservation, transplant immunology, and airway biology. His published works include participation in the 2023 version of the NCCN’s Clinical Practice Guidelines in Oncology for the treatment of peritoneal mesothelioma and a work on the early detection of lung cancer using artificial intelligence-enhanced optical nanosensing of chromatin alterations in field carcinogenesis.


This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.


LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.

Commentaires


bottom of page